USANA Health Sciences Inc (United States) is listed on the Nasdaq and has a market capitalization of $245.70 million, with shareholders equity totaling $570.97 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, USANA Health Sciences Inc reported $913.36 million in revenue, generating net income of $-22.71 million.
Key financial metrics include a P/E ratio of -10.82, a price-to-book (P/B) ratio of 0.43, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker USNA.